Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Poland Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20101
20112
20122
20133
20141
20154
20163
20174
20182
20193
20204
20214
20224
20233
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting7
Terminated7
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Bristol-Myers Squibb3
MedImmune LLC3
Novartis Pharmaceuticals3
AbbVie2
EMD Serono2
EMD Serono Research & Development Institute, Inc.2
Eli Lilly and Company2
GlaxoSmithKline2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic49
Autoimmune Diseases5
Lupus Erythematosus, Cutaneous4
Connective Tissue Diseases3
Immune System Diseases3
Arthritis, Rheumatoid2
Lupus Erythematosus, Discoid2
Lupus Nephritis2

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.